Top-line data from the trial evaluating phentolamine ophthalmic solution 0.75% for the treatment of presbyopia are expected in 2025.

This year's theme, "Love Your Eyes," focuses on children's vision and eye health.

The new, non-diffractive IOLs are the second generation of BVI’s ISOPURE premium monofocal IOL that was launched in 2019.

A team of researchers from Johns Hopkins Medicine and the University of Wisconsin-Madison conducted a study on the application of autonomous artificial intelligence LumineticsCore and testing for diabetic eye disease.

According to the UK study, for every 0.5-diopter increase in mean spherical equivalent, a 6% higher risk was attributed in developing depressive disorders.

Smart contact lenses can be used to correct vision, monitor the health of the user, and flag and treat diseases for patients diagnosed with chronic health conditions such as glaucoma and diabetes.

In this episode, four expert faculty talk about the importance of early diagnosis and treatment of thyroid eye disease. They discuss the differential diagnosis, screening tests, and the need for multidisciplinary management for these patients.

Catch up on what happened in optometry during the week of August 26-August 30.

AOA associate members have access to services, programs, educational materials, and discounts on event registration fees, according to a news release.

Researchers at the Medical College of Georgia at Augusta University are teaming up with Polaris Dawn to investigate how eye changes astronauts may experience during spaceflight could lead to multiple symptoms once back on Earth.

Injectsense's future plans for the sensor are to fine-tune its delivery tool and incorporate a microbattery into the sensor.

The RayOne Galaxy and Galaxy Toric IOL will launch at this year's ESCRS Congress in Barcelona, Spain.

It's time for back-to-school eye exams, and host Miriam Korik, OD, teams up with Eyes Up host Damaris Raymondi, OD, FAAO, to chat about how to handle pediatric eye exams efficiently, thoroughly, and confidently.

The strike force involves more than a dozen medical and nonmedical professionals to help bridge the gap between failed vision screenings and follow-up examinations.

The product candidate is a modifier gene therapy for broad retinitis pigmentosa indication.

With strabismus making headlines after Stephen Nedoroscik's performance at the 2024 Olympic Games, Dr. Lojka overviews the condition and how optometrists can care for athletes with eye conditions.

Taking a contemporary approach to prostaglandin analog therapy.

Catch up on what happened in optometry during the week of August 19-August 23.

Recent studies that have reported that active and healthy living can reduce IOP.